NEW YORK / Nov 18, 2024 / Business Wire / DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in November:
Southwest Ideas Conference (November 20th)
Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings, and deliver a presentation on Wednesday November 20th at 5:10 PM ET. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.
Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum (November 21st)
Lee Bienstock, Chief Executive Officer will hold 1x1 meetings at this event. Contact your Canaccord representative for additional details.
BTIG Digital Health Forum (November 25th)
Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings and on a panel titled Care Coordination, Gap Closures and Lower Cost Sites of Service at 9:00 AM ET. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.
About DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient’s home or workplace. Together with DocGo’s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com. To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit www.proactivecarenow.com.
Last Trade: | US$4.25 |
Daily Change: | 0.03 0.71 |
Daily Volume: | 258,251 |
Market Cap: | US$431.500M |
December 18, 2024 December 10, 2024 December 04, 2024 November 26, 2024 November 07, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load